Sensible Biotechnologies
Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform for the production of therapeutics. The platform aims to produce pure, low immunogenicity mRNA to overcome the limitations of synthetic mRNA. The company utilizes a computational engine for design and partners with manufacturing firms to scale its cell-based production technology.
Visit websiteOxford, UK
Biotechnology
Healthtech
Therapeutics
Funding summary
- Total raised
- €3.8M
- Funding rounds
- 1
Investors in Sensible Biotechnologies
Investors on record for Sensible Biotechnologies. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Sensible Biotechnologies?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors